Biomaterial design strategies for enhancing mitochondrial transplantation therapy
BMEMat, EarlyView.Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang +12 more
wiley +1 more source
Mechanical circulatory support: Technical tips for the implantation of a right ventricular assist device. [PDF]
JTCVS Open, 2021 Potapov E +3 more
europepmc +1 more source
Performance evaluation of a pulsatile ventricular assist device under non physiologic pumping frequencies by means FEM and 2D approach [PDF]
, 2017 A ventricular assist device (VAD) is a blood pump that works in parallel with heart. It is used as a mechanical assistance for patients that suffer cardiac insufficiency: as a therapy, as a bridge to transplant or to extend life.
Di Paolo, José, Fríes, Exequiel R.
core
, 2002 BACKGROUND: Right ventricular assist devices (RVADs) have been proposed to improve exposure of the coronary arteries in off-pump surgery. In this study we investigated the impact of the A-Med RVAD on inflammatory response and organ function in patients ...
Angelini, Gianni D +6 more
core +1 more source
Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation [PDF]
, 2015 Guson Kang +2 more
openalex +1 more source
Contemporary and Emerging Therapies in the Management of Refractory Angina: A Clinical Review
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Refractory angina (RA) represents a growing challenge in clinical cardiology, particularly in patients with obstructive coronary artery disease (CAD) who remain symptomatic despite optimal medical therapy and who are not candidates for revascularization.
Alex Angers‐Goulet +4 more
wiley +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Soluble suppression of tumorigenicity‐2 (sST2) predicts mortality in patients with heart failure. The predictive value of sST2 in patients with a left ventricular assist device remains unknown.
Lieke Numan +9 more
doaj +1 more source
3 Cases of Superior Vena Cava Syndrome Following Percutaneous Right Ventricular Assist Device Placement. [PDF]
JACC Case Rep, 2021 Vaile JR +8 more
europepmc +1 more source
Right ventricular failure after left ventricular assist device implantation with concomitant pulmonary embolectomy needing right ventricular assist device support in a patient with terminal heart failure and asymptomatic pulmonary thrombus [PDF]
, 2009 Alexander Stepanenko +3 more
openalex +1 more source